Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study

Jose M Garcia; Ying Yan; Elizabeth Manning-Duus; John Friend

首页> 外文期刊>Cancer & Metabolism >Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study

【24h】

Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study

机译：生长激素释放肽受体激动剂阿那莫林对恶病质癌症患者瘦体重的影响; II期随机，双盲，多中心研究的结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer & Metabolism》 |2014年第s1期|共页
作者
Jose M Garcia; Ying Yan; Elizabeth Manning-Duus; John Friend;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-18 06:06:33

相似文献

外文文献
中文文献

1. Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. [J] . José M Garcia, John Friend, Suzan Allen Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2013,第1期

机译：Anamorelin（一种新型的口服生长激素释放肽模拟物）在与癌症相关的恶病质患者中的治疗潜力：一项多中心，随机，双盲，交叉，前瞻性研究。
2. Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of Japanese patients (ONO‐7643‐04) [J] . Katakami Nobuyuki, Uchino Junji, Yokoyama Takuma, Cancer: A Journal of the American Cancer Society . 2018,第3期

机译：Anamorelin（ONO-7643）用于治疗非小细胞肺癌和恶病症的患者：随机，双盲，安慰剂控制，日本患者的多中心研究结果（ONO-7643-04）
3. Glucose-lowering effects and safety of DS-8500a, a G protein-coupled receptor 119 agonist, in Japanese patients with type 2 diabetes: results of a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase II study [J] . Nobuya Inagaki, Shuji Tsukiyama, Takashi Taguchi, BMJ Open Diabetes Research & Care . 2017,第1期

机译：DS-2500a（一种G蛋白偶联受体119激动剂）在日本2型糖尿病患者中的降糖作用和安全性：一项随机，双盲，安慰剂对照，平行组，多中心，II期研究的结果
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Effect of leucine supplementation on loss of lean body mass during prolonged hypoxic exposure: A double-blind randomized study. [D] . Gershenoff, Dana Carla. 2013

机译：补充亮氨酸对长时间缺氧暴露期间瘦体重的影响：一项双盲随机研究。
6. Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized double blind multicenter study [O] . Jose M Garcia, Ying Yan, Elizabeth Manning-Duus, 2014

机译：生长激素释放肽受体激动剂阿那莫林对恶病质癌症患者瘦体重的影响； II期随机双盲多中心研究的结果
7. Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study [O] . Jose M Garcia, Ying Yan, Elizabeth Manning-Duus, 2014

机译：生长激素释放肽受体激动剂阿那莫林对恶病质癌症患者瘦体重的影响； II期随机，双盲，多中心研究的结果

Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study

著录项

相似文献

相关主题

期刊订阅